AACAP+CACAP Joint Annual Meeting
Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.


New Research Poster Presentation 1.25
Effects of STX209 (arbaclofen) on Social and Communicative Function in Autism Spectrum Disorder: Results of an 8-Week Open-Label Trial

Wednesday, October 19, 2011
Craig A. Erickson, M.D., Psychiatry, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN
Lawrence Ginsberg, M.D., Red Oak Psychiatry Associates, Houston, TX
Jeremy Veenstra-VanderWeele, M.D., Kennedy Center for Research on Human Development, Nashville, TN
Raun Melmed, M.D., Southwest Autism Research and Resource Center, Scottsdale, AZ
Linmarie Sikich, M.D., University of North Carolina at Chapel Hill, Chapel Hill, NC
Lawrence Scahill, M.S.N., Ph.D., Yale Child Study Center, New Haven, CT
James T. McCracken, M.D., Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
Barbara Rathmell, M.D., Seaside Therapeutics, Inc., Cambridge, MA
Randall L. Carpenter, M.D., Seaside Therapeutics, Inc., Cambridge, MA
Paul Wang, M.D., Seaside Therapeutics, Inc., Cambridge, MA
Mark Bear, Ph.D., The Picower Institute for Learning and Memory, Cambridge, MA
Bryan H. King, M.D., Department of Child and Adolescent Psychiatry, University of Washington, Seattle Children's Hospital, Seattle, WA